Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis

Circulation

Volumn 134, Issue 6, 2016, Pages 455-468

  Nielsen, Olav W ^a   Sajadieh, Ahmad ^a   Sabbah, Muhammad ^a   Greve, Anders M ^a   Olsen, Michael H ^b,c   Boman, Kurt ^d   Nienaber, Christoph A ^e   Kesäniemi, Y Antero ^f   Pedersen, Terje R ^g   Willenheimer, Ronnie ^h   Wachtell, Kristian ^g  

^a BISPEBJERG HOSPITAL   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UMEÅ UNIVERSITY   (Sweden)

^e ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^f UNIVERSITY OF OULU   (Finland)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h Heart Health Group   (Sweden)

Author keywords

aortic valve stenosis; blood pressure; hypertension; mortality; prognosis

Indexed keywords

ADULT; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; AGED; AORTIC VALVE STENOSIS; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

AGED; ANTICHOLESTEREMIC AGENTS; AORTIC VALVE STENOSIS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EZETIMIBE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; SIMVASTATIN;

EID: 85000631199     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.021213     Document Type: Article

References (18)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29: 630-634.
2. Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E. Hypertension in aortic stenosis: implications for left ventricular structure, and cardiovascular events. Hypertension. 2012; 60: 90-97. doi: 10.1161/.HYPERTENSIONAHA.112.194878.
3. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. SEAS Investigators. Intensive lipid lowering with simvastatin, and ezetimibe in aortic stenosis. N Engl J Med. 2008; 359: 1343-1356. doi: 10.1056/NEJMoa0804602.
4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: e521-e643. doi: 10.1161/CIR.0000000000000031.
5. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Design, and baseline characteristics of the Simvastatin, and Ezetimibe in Aortic Stenosis (SEAS) study. Am J Cardiol. 2007; 99: 970-973. doi: 10.1016/j.amjcard.2006.10.064.
6. Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, Wachtell K, Gerdts E. Low-flow aortic stenosis in asymptomatic patients: valvular-Arterial impedance, and systolic function from the SEAS Substudy. JACC Cardiovasc Imaging. 2009; 2: 390-399. doi: 10.1016/j.jcmg.2008.12.021.
7. Carabello BA. What is new in the 2006 ACC/AHA guidelines on valvular heart disease? Curr Cardiol Rep. 2008; 10: 85-90.
8. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M. EAE/.ASE. Echocardiographic assessment of valve stenosis: EAE/.ASE recommendations for clinical practice. Eur J Echocardiogr. 2009; 10: 1-25. doi: 10.1093/ejechocard/jen303.
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450-458.
10. Chockalingam A, Venkatesan S, Subramaniam T, Jagannathan V, Elangovan S, Alagesan R, Gnanavelu G, Dorairajan S, Krishna BP, Chockalingam V. Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis. Safety, and efficacy of angiotensinconverting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J. 2004; 147: E19. doi: 10.1016/j.ahj.2003.10.017.
11. Bang CN, Greve AM, Køber L, Rossebø AB, Ray S, Boman K, Nienaber CA, Devereux RB, Wachtell K. Renin-Angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis. Int J Cardiol. 2014; 175: 492-498. doi: 10.1016/j. ijcard.2014.06.013.
12. Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. PROVE IT-TIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure, and cardiovascular events in the PRavastatin OR atorVastatin Evaluation, and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010; 122: 2142-2151. doi: 10.1161/CIRCULA TIONAHA.109.905687.
13. Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R, Pepine CJ. INVEST Investigators. Clinical outcomes in the diabetes cohort of the INterNational VErapamil SR-Trandolapril study. Hypertension. 2004; 44: 637-642. doi: 10.1161/01. HYP.0000143851.23721.26.
14. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/.jama.2013.284427.
15. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH), and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159-2219. doi: 10.1093/eurheartj/eht151.
16. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373: 2103-2116.
17. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Effects of intensive blood pressure lowering on cardiovascular, and renal outcomes: updated systematic review, and meta-Analysis. Lancet. 2016; 387: 435-443. doi: 10.1016/S0140-6736(15)00805-3.
18. Lindman BR, Otto CM. Time to treat hypertension in patients with aortic stenosis. Circulation. 2013; 128: 1281-1283. doi: 10.1161/CIRCULATIONAHA.113.005275.